Furthermore, recent studies have disclosed that amlodipine also exhibits anti-tumor effects on breast and lung cancer by inhibiting cell proliferation, inducing cell cycle arrest and promoting apoptosis, through suppression of the EGFR-Akt/mTOR or Raf/MEK/ERK pathways, instead of CCB activity [17–19]. Here, EGFR is linked to neoplasm.